Michael Strader

The Path to Precision in Acute Kidney Injury "The Path to Precision in Acute Kidney Injury" published on 06 Jun 2025 by American Society of Nephrology.

The future is precise and found in liquid gold.

The Path to Precision in Acute Kidney Injury doi.org/10.62716/kn....

Box: Summary of main changes in CONSORT 2025. Copyright: 2025 The Author(s). Published by Elsevier Ltd. CC BY 4.0

CONSORT 2025 statement: updated guideline for reporting randomised trials

🔗 tinyurl.com/2s3hv3yx

Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension | NEJM Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...

www.nejm.org/doi/full/10....

Prospective Study of a #PointOfCare #Diagnostic Test for Acute Kidney Injury #AKI in a South Asian Hospital

#VisualAbstract by @krishnadoctor1

www.kireports.org/ar...

Irish flag flying on the Parliament building

Our March issue is live! Our editorial highlights Ireland’s outlier status in European primary health care. It is the only EU country without universal primary care, leaving 58% of residents without free access. It’s time for Ireland to align with European standards www.thelancet.com/journals/lan...

Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers We evaluated a panel of novel urinary and serum biomarkers (BMs) for early and sensitive detection of cisplatin drug-induced kidney injury (DIKI) in patients with cancer, comparing their diagnostic ac...

Excited to show the sub-clinical AKI we are missing with Cr and the benefit of novel BMs (FDA approved panel for nephrotoxicity) - Kidney International Reports www.kireports.org/article/S246...